The causative agents in infective endocarditis: A systematic review comprising 33,214 cases

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 35, Issue 8, 2016, Pages 1227-1245

  Vogkou, Christiana T ^a,b   Vlachogiannis, Nikolaos I ^a,b   Palaiodimos, Leonidas ^a,c   Kousoulis, Antonis A ^a,d  

^a National and Kapodistrian University of Athens ^*  (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASIA; BACTERIAL ENDOCARDITIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONGENITAL HEART MALFORMATION; ENTEROCOCCUS; EVIDENCE BASED PRACTICE; FUNGAL ENDOCARDITIS; HUMAN; IMMUNOCOMPROMISED PATIENT; MEDLINE; MICROBIOLOGY; NONHUMAN; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS EQUINUS; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; AGED; CHILD; ENDOCARDITIS, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; STAPHYLOCOCCUS; STREPTOCOCCUS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; STAPHYLOCOCCUS; STREPTOCOCCUS; YOUNG ADULT;

EID: 85027931858     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-016-2660-6     Document Type: Review

References (126)

1. Thuny F, Grisoli D, Collart F, Habib G, Raoult D (2012) Management of infective endocarditis: challenges and perspectives. Lancet 379:965–975
2. Habib G (2006) Management of infective endocarditis. Heart 92: 124–130. doi:10.1136/hrt.2005.063719
3. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS et al (2009) Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169:463–473. doi:10.1001/archinternmed.2008.603
4. Thuny F, Hubert S, Tribouilloy C, Le Dolley Y, Casalta JP, Riberi A et al (2013) Sudden death in patients with infective endocarditis: findings from a large cohort study. Int J Cardiol 162:129–132
5. Htwe TH, Khardori NM (2012) Cardiac emergencies. Med Clin N Am 96:1149–1169. doi:10.1016/j.mcna.2012.09.003
6. Tornos P, Gonzalez-Alujas T, Thuny F, Habib G (2011) Infective endocarditis: the European viewpoint. Curr Probl Cardiol 36:175– 222. doi:10.1016/j.cpcardiol.2011.03.004
7. Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi M-F, Barsic B, Bouza E et al (2008) Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med 168:2095–2103. doi:10.1001/archinte.168.19.2095
8. Sousa C, Botelho C, Rodrigues D, Azeredo J, Oliveira R (2012) Infective endocarditis in intravenous drug abusers: an update. Eur J Clin Microbiol Infect Dis 31:2905–2910. doi:10.1007/s10096-012-1675-x
9. Ortiz-Bautista C, López J, García-Granja PE, Sevilla T, Vilacosta I, Sarriá C et al (2015) Current profile of infective endocarditis in intravenous drug users: the prognostic relevance of the valves involved. Int J Cardiol 187:472–474. doi:10.1016/j.ijcard.2015. 03.368
10. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ et al (2002) Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 162:90–94
11. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR et al (2004) Increasing rates of cardiac device infections among medicare beneficiaries: 1990–1999. Am Heart J 147:582–586. doi:10.1016/j.ahj.2003.06.005
12. Nakagawa T, Wada H, Sakakura K, Yamada Y, Ishida K, Ibe T et al (2014) Clinical features of infective endocarditis: comparison between the 1990s and 2000s. J Cardiol 63:145–148. doi:10.1016/j.jjcc.2013.06.007
13. Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E et al (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012–3021
14. Gregor P (2013) What’s new in the prevention of infective endocarditis? Cor Vasa 55:e520–e524. doi:10.1016/j.crvasa.2013.05. 006
15. Kang D-H, Kim Y-J, Kim S-H, Sun BJ, Kim D-H, Yun S-C et al (2012) Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 366:2466–2473
16. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 349:g7647–g7647. doi:10.1136/bmj.g7647
17. Chirillo F, Bacchion F, Pedrocco A, Scotton P, De Leo A, Rocco F et al (2010) Infective endocarditis in patients with diabetes mellitus. J Heart Valve Dis 19:312–320
18. Mokhles MM, Ciampichetti I, van Domburg R, Cheng JM, Bogers AJJC, Witsenburg M (2012) Infective endocarditis in a tertiary referral hospital: long-term follow up. J Heart Valve Dis 21:118–124
19. Yamane K, Hirose H, Bogar LJ, Cavarocchi NC, Diehl JT (2012) Surgical treatment of infective endocarditis in patients undergoing chronic hemodialysis. J Heart Valve Dis 21:774–782
20. Pazdernik M, Baddour LM, Pelouch R (2009) Infective endocarditis in the Czech Republic: eight years of experience at one of the country’s largest medical centers. J Heart Valve Dis 18:395–400
21. Niwa K (2005) Infective endocarditis in congenital heart disease: Japanese national collaboration study. Heart 91:795–800. doi:10. 1136/hrt.2004.043323
22. Tribouilloy C, Rusinaru D, Sorel C, Thuny F, Casalta J-P, Riberi A et al (2010) Clinical characteristics and outcome of infective endocarditis in adults with bicuspid aortic valves: a multicentre observational study. Heart 96:1723–1729. doi:10.1136/hrt.2009. 189050
23. Lalani T, Kanafani ZA, Chu VH, Moore L, Corey GR, Pappas P et al (2006) Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database. Eur J Clin Microbiol Infect Dis 25:365–368. doi:10.1007/s10096-006-0141-z
24. Abramczuk E, Hryniewiecki T, Stepińska J (2007) Effects of pathogenic factors on prognosis in patients with prosthetic valve endocarditis. Kardiol Pol 65:115–122, discussion 123–4
25. Marom D, Ashkenazi S, Samra Z, Birk E (2013) Infective endocarditis in previously healthy children with structurally normal hearts. Pediatr Cardiol 34:1415–1421. doi:10.1007/s00246-013-0665-9
26. Lin Y-T, Hsieh K-S, Chen Y-S, Huang I-F, Cheng M-F (2013) Infective endocarditis in children without underlying heart disease. J Microbiol Immunol Infect 46:121–128. doi:10.1016/j. jmii.2012.05.001
27. Sandre RM, Shafran SD (1996) Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis Off Publ Infect Dis Soc Am 22:276–286
28. Levinson DC, Griffith GC, Pearson HE (1950) Increasing bacterial resistance to the antibiotics; a study of 46 cases of streptococcus endocarditis and 18 cases of staphylococcus endocarditis. Circulation 2:668–675
29. Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS et al (2013) Infective endocarditis epidemiology over five decades: a systematic review. PLoS ONE 8:e82665. doi:10.1371/journal.pone.0082665
30. Bashore TM, Cabell C, Fowler V Jr (2006) Update on infective endocarditis. Curr Probl Cardiol 31:274–352. doi:10.1016/j. cpcardiol.2005.12.001
31. McDonald JR (2009) Acute infective endocarditis. Infect Dis Clin N Am 23:643–664. doi:10.1016/j.idc.2009.04.013
32. Di Filippo S (2006) Current patterns of infective endocarditis in congenital heart disease. Heart 92:1490–1495. doi:10.1136/hrt. 2005.085332
33. Fortún J, Centella T, Martín-Dávila P, Lamas MJ, Pérez-Caballero C, Fernández-Pineda L et al (2013) Infective endocarditis in congenital heart disease: a frequent community-acquired complication. Infection 41:167–174. doi:10.1007/s15010-012-0326-6
34. Takeda S, Nakanishi T, Nakazawa M (2005) A 28-year trend of infective endocarditis associated with congenital heart diseases: a single institute experience. Pediatr Int 47:392–396
35. Rosenthal LB, Feja KN, Levasseur SM, Alba LR, Gersony W, Saiman L (2010) The changing epidemiology of pediatric endocarditis at a children’s hospital over seven decades. Pediatr Cardiol 31:813–820. doi:10.1007/s00246-010-9709-6
36. Thanavaro KL, Nixon JV (2014) Endocarditis 2014: an update. Heart Lung 43:334–337. doi:10.1016/j.hrtlng.2014.03.009
37. Dinnes J, Deeks J, Kirby J, Roderick P (2005) A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technol Assess Winch Engl 9:1–113, iii
38. Srifuengfung S, Yungyuen T, Komolpis P (2004) Bacterial isolation and antimicrobial susceptibilities in patients with infective endocarditis. Southeast Asian J Trop Med Public Health 35:897– 901
39. Koegelenberg CFN (2003) Infective endocarditis in the Western Cape Province of South Africa: a three-year prospective study. QJM 96:217–225. doi:10.1093/qjmed/hcg028
40. Ako J, Ikari Y, Hatori M, Hara K, Ouchi Y (2003) Changing spectrum of infective endocarditis. Review of 194 episodes over 20 years. Circ J 67:3–7
41. Coward K, Tucker N, Darville T (2003) Infective endocarditis in Arkansan children from 1990 through 2002. Pediatr Infect Dis J 22:1048–1052
42. Valencia Ortega ME, Guinea J, Enrique A, Ortega G, Moreno V, Gonzalez Lahoz J (2003) Study of 42 cases of infective endocarditis in the HAART era in Spain. Clin Microbiol Infect 9:1073– 1075
43. Nakatani S, Mitsutake K, Hozumi T, Yoshikawa J, Akiyama M, Yoshida K et al (2003) Current characteristics of infective endocarditis in Japan-an analysis of 848 cases in 2000 and 2001. Circ J 67:901–905
44. Di Salvo G (2003) Endocarditis in the elderly: clinical, echocar-diographic, and prognostic features. Eur Heart J 24:1576–1583. doi:10.1016/S0195-668X(03)00309-9
45. Bishara J, Peled N, Samra Z, Sagie A, Leibovici L, Pitlik S (2004) Infective endocarditis in diabetic and non-diabetic patients. Scand J Infect Dis 36:795–798. doi:10.1080/00365540410025384
46. Rundström H, Kennergren C, Andersson R, Alestig K, Hogevik H (2004) Pacemaker endocarditis during 18 years in Göteborg. Scand J Infect Dis 36:674–679. doi:10.1080/00365540410022611
47. Spies C, Madison JR, Schatz IJ (2004) Infective endocarditis in patients with end-stage renal disease: clinical presentation and outcome. Arch Intern Med 164:71–75. doi:10.1001/archinte.164. 1.71
48. Duval X, Suty CS, Alla F, Salvador-Mazenq M, Bernard Y, Weber M et al (2004) Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis 39:68–74
49. Loupa C, Mavroidi N, Boutsikakis I, Paniara O, Deligarou O, Manoli H et al (2004) Infective endocarditis in Greece: a changing profile. Epidemiological, microbiological and therapeutic data. Clin Microbiol Infect 10:556–561. doi:10.1111/j.1469-0691. 2004.00884.x
50. Cecchi E, Forno D, Imazio M, Migliardi A, Gnavi R, Dal Conte I et al (2004) New trends in the epidemiological and clinical features of infective endocarditis: results of a multicenter prospective study. Ital Heart J Off J Ital Fed Cardiol 5:249–256
51. Tariq M, Alam M, Munir G, Khan MA, Smego RA (2004) Infective endocarditis: a five-year experience at a tertiary care hospital in Pakistan. Int J Infect Dis 8:163–170. doi:10.1016/j. ijid.2004.02.001
52. Barrau K, Boulamery A, Imbert G, Casalta J-P, Habib G, Messana T et al (2004) Causative organisms of infective endocarditis according to host status. Clin Microbiol Infect 10:302–308. doi:10. 1111/j.1198-743X.2004.00776.x
53. Ben-Ami R, Giladi M, Carmeli Y, Orni-Wasserlauf R, Siegman- Igra Y (2004) Hospital-acquired infective endocarditis: should the definition be broadened? Clin Infect Dis 38:843–850
54. Liew WK, Tan TH, Wong KY (2004) Infective endocarditis in childhood: a seven-year experience. Singapore Med J 45:525–529
55. Chu J, Wilkins G, Williams M (2004) Review of 65 cases of infective endocarditis in Dunedin Public Hospital. N Z Med J 117:U1021
56. Mourvillier B, Trouillet J-L, Timsit J-F, Baudot J, Chastre J, Régnier B et al (2004) Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Intensive Care Med 30:2046–2052. doi:10.1007/s00134-004-2436-9
57. Tleyjeh IM, Steckelberg JM, Murad HS, Anavekar NS, Ghomrawi HM, Mirzoyev Z et al (2005) Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 293:3022–3028
58. Lewena S (2005) Infective endocarditis: experience of a paediatric emergency department. J Paediatr Child Health 41:269–272
59. Ruttmann E, Bonatti H, Legit C, Ulmer H, Stelzmueller I, Antretter H et al (2005) Severe endocarditis in transplant recipients - an epidemiologic study. Transpl Int 18:690–696. doi:10. 1111/j.1432-2277.2005.00120.x
60. Garg N, Kandpal B, Garg N, Tewari S, Kapoor A, Goel P et al (2005) Characteristics of infective endocarditis in a developing country-clinical profile and outcome in 192 Indian patients, 1992–2001. Int J Cardiol 98:253–260. doi:10.1016/j.ijcard.2003. 10.043
61. Benslimani A, Fenollar F, Lepidi H, Raoult D (2005) Bacterial zoonoses and infective endocarditis, Algeria. Emerg Infect Dis 11:216
62. Hsu C-N, Wang J-Y, Tseng C-D, Hwang J-J, Hsueh P-R, Liau C-S (2006) Clinical features and predictors for mortality in patients with infective endocarditis at a university hospital in Taiwan from 1995 to 2003. Epidemiol Infect 134:589. doi:10.1017/S0950268805005224
63. Martín-Dávila P, Fortún J, Navas E, Cobo J, Jiménez-Mena M, Moya JL et al (2005) Nosocomial endocarditis in a tertiary hospital: an increasing trend in native valve cases. Chest 128:772–779. doi:10.1378/chest.128.2.772
64. Tissières P, Jaeggi ET, Beghetti M, Gervaix A (2005) Increase of fungal endocarditis in children. Infection 33:267–272. doi:10. 1007/s15010-005-4122-4
65. Thach Tran C, Kjeldsen K (2006) Endocarditis at a tertiary hospital: Reduced acute mortality but poor long term prognosis. Scand J Infect Dis 38:664–670. doi:10.1080/00365540600585180
66. Roca B, Marco JM (2007) Presentation and outcome of infective endocarditis in Spain: a retrospective study. Int J Infect Dis 11: 198–203. doi:10.1016/j.ijid.2006.04.002
67. Walpot J, Blok W, van Zwienen J, Klazen C, Amsel B (2006) Incidence and complication rate of infective endocarditis in the Dutch region of Walcheren: a 3-year retrospective study. Acta Cardiol 61:175–181
68. Cicalini S, Puro V, Angeletti C, Chinello P, Macrì G, Petrosillo N (2006) Profile of infective endocarditis in a referral hospital over the last 24 years. J Infect 52:140–146. doi:10.1016/j.jinf.2005.02. 025
69. Heiro M (2006) Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980–2004. Heart 92: 1457–1462. doi:10.1136/hrt.2005.084715
70. Ferreiros E, Nacinovich F, Casabé JH, Modenesi JC, Swieszkowski S, Cortes C et al (2006) Epidemiologic, clinical, and microbiologic profile of infective endocarditis in Argentina: a national survey. The Endocarditis Infecciosa en la República Argentina–2 (EIRA-2) Study. Am Heart J 151:545–552. doi:10. 1016/j.ahj.2005.04.008
71. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods M-C, Peetermans WE (2006) Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 28:196–203. doi:10.1093/eurheartj/ehl427
72. Yiu K-H, Siu C-W, Lee KL-F, Fong Y-T, Chan H-W, Lee SW-L et al (2007) Emerging trends of community acquired infective endocarditis. Int J Cardiol 121:119–122. doi:10.1016/j.ijcard.2006.08. 053
73. Gebo KA, Burkey MD, Lucas GM, Moore RD, Wilson LE (2006) Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 43:426–432
74. Abramczuk E, Hryniewiecki T, Stepińska J (2006) Influence of pathogenetic factors on prognosis in patients with native valve infective endocarditis. Kardiol Pol 64:675–681, discussion 682–3
75. De Rosa FG, Cicalini S, Canta F, Audagnotto S, Cecchi E, Di Perri G (2007) Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients. Infection 35:154–160. doi:10.1007/s15010-007-5125-0
76. Nashmi A, Memish ZA (2007) Infective endocarditis at a tertiary care centre in Saudi Arabia: review of 47 cases over 10 years. East Mediterr Health J 13(1):64–71
77. Kamalakannan D, Pai RM, Johnson LB, Gardin JM, Saravolatz LD (2007) Epidemiology and clinical outcomes of infective endocarditis in hemodialysis patients. Ann Thorac Surg 83:2081–2086. doi:10.1016/j.athoracsur.2007.02.033
78. Giannitsioti E, Skiadas I, Antoniadou A, Tsiodras S, Kanavos K, Triantafyllidi H et al (2007) Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk. Clin Microbiol Infect 13:763–769. doi:10. 1111/j.1469-0691.2007.01746.x
79. Wang A, Athan E, Pappas PA, Fowler VG, Olaison L, Paré C et al (2007) Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 297:1354–1361. doi:10.1001/jama. 297.12.1354
80. Letaief A, Boughzala E, Kaabia N, Ernez S, Abid F, Chaabane TB et al (2007) Epidemiology of infective endocarditis in Tunisia: a 10-year multicenter retrospective study. Int J Infect Dis 11:430– 433. doi:10.1016/j.ijid.2006.10.006
81. Krecki R, Drozdz J, Ibata G, Lipiec P, Ostrowski S, Kasprzak J et al (2007) Clinical profile, prognosis and treatment of patients with infective endocarditis—a 14-year follow-up study. Pol Arch Med Wewnętrznej 117:512–520
82. Lee C-H, Tsai W-C, Liu P-Y, Tsai L-M, Ho M-T, Chen J-H et al (2007) Epidemiologic features of infective endocarditis in Taiwanese adults involving native valves. Am J Cardiol 100: 1282–1285. doi:10.1016/j.amjcard.2007.05.053
83. Hricak V, Liska B, Kovackova J, Mikusova J, Fischer V, Kovacik J et al (2007) Trends in risk factors and etiology of 606 cases of infective endocarditis over 23 years (1984–2006) in slovakia. J Chemother Florence Italy 19:198–202. doi:10.1179/joc.2007.19. 2.198
84. Alshammary A, Hervas-Malo M, Robinson JL (2008) Pediatric infective endocarditis: has Staphylococcus aureus overtaken viridans group streptococci as the predominant etiological agent? Can J Infect Dis Med Microbiol 19:63
85. Siegman-igra Y, Koifman B, Porat R, Porat D, Giladi M (2008) Healthcare associated infective endocarditis: a distinct entity. Scand J Infect Dis 40:474–480. doi:10.1080/00365540701837357
86. Jain V, Yang M-H, Kovacicova-Lezcano G, Juhle LS, Bolger AF, Winston LG (2008) Infective endocarditis in an urban medical center: association of individual drugs with valvular involvement. J Infect 57:132–138. doi:10.1016/j.jinf.2008.05.008
87. Fernández-Hidalgo N, Almirante B, Tornos P, Pigrau C, Sambola A, Igual A et al (2008) Contemporary epidemiology and prognosis of health care–associated infective endocarditis. Clin Infect Dis 47:1287–1297. doi:10.1086/592576
88. Day MD, Gauvreau K, Shulman S, Newburger JW (2009) Characteristics of children hospitalized with infective endocarditis. Circulation 119:865–870. doi:10.1161/CIRCULATIONAHA. 108.798751
89. Chao P-J, Hsu C-H, Liu Y-C, Sy C-L, Chen Y-S, Wann S-R et al (2009) Clinical and molecular epidemiology of infective endocarditis in intravenous drug users. J Chin Med Assoc JCMA 72:629–633. doi:10.1016/S1726-4901(09)70444-7
90. Wong CW, Porter G, Tisch J, Young C (2009) Outcome and prognostic factors on 57 cases of infective endocarditis in a single centre. N Z Med J 122:54–62
91. Al-Tawfiq JA, Sufi I (2009) Infective endocarditis at a hospital in Saudi Arabia: epidemiology, bacterial pathogens and outcome. Ann Saudi Med 29:433–436. doi:10.4103/0256-4947.57164
92. Nunes MCP, Gelape CL, Ferrari TCA (2010) Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors and in-hospital outcome. Int J Infect Dis 14:e394–e398. doi:10.1016/j.ijid.2009.06.024
93. Tuğcu A, Yildirimtürk O, Baytaroğlu C, Kurtoğlu H, Köse O, Sener M et al (2009) Clinical spectrum, presentation, and risk factors for mortality in infective endocarditis: a review of 68 cases at a tertiary care center in Turkey. Turk Kardiyol Dern Ars 37:9– 18
94. Le V, Gill S (2010) Serious complications after infective endocarditis. Dan Med Bull 57:A4192
95. Sy RW, Kritharides L (2010) Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J 31:1890– 1897. doi:10.1093/eurheartj/ehq110
96. Lomas JM, Martínez-Marcos FJ, Plata A, Ivanova R, Gálvez J, Ruiz J et al (2010) Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalization. Clin Microbiol Infect 16:1683–1690. doi:10.1111/j.1469-0691.2010.03043.x
97. Saydain G, Singh J, Dalal B, Yoo W, Levine DP (2010) Outcome of patients with injection drug use–associated endocarditis admitted to an intensive care unit. J Crit Care 25:248–253. doi:10.1016/j.jcrc.2009.09.007
98. Siegman-Igra Y (2010) Infective endocarditis following gastrointestinal and genitourinary procedures: an argument in favour of prophylaxis. Scand J Infect Dis 42:208–214. doi:10.3109/00365540903443140
99. Khan NU, Farman MT, Sial JA, Achakzai AS, Saghir T, Ishaq M (2010) Changing trends of infective endocarditis. J Pak Med Assoc 60:24–27
100. Rostagno C, Rosso G, Puggelli F, Gelsomino S, Braconi L, Montesi GF et al (2010) Active infective endocarditis: clinical characteristics and factors related to hospital mortality. Cardiol J 17:566–573
101. Takayama Y, Okamoto R, Sunakawa K (2010) Definite infective endocarditis: clinical and microbiological features of 155 episodes in one Japanese university hospital. J Formos Med Assoc Taiwan Yi Zhi 109:788–799. doi:10.1016/S0929-6646(10)60124-6
102. Sucu M, Davutoğlu V, Özer O, Aksoy M (2010) Epidemiological, clinical and microbiological profile of infective endocarditis in a tertiary hospital in the South-East Anatolia Region. Congest Heart Fail 23:31–39
103. de Sa DDC, Tleyjeh IM, Anavekar NS, Schultz JC, Thomas JM, Lahr BD et al (2010) Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc 85:422–426. doi:10.4065/mcp.2009.0585
104. Demonchy E, Dellamonica P, Roger PM, Bernard E, Cua E, Pulcini C (2011) Audit of antibiotic therapy used in 66 cases of endocarditis. Médecine Mal Infect 41:602–607. doi:10.1016/j. medmal.2011.08.003
105. Wu K-S, Lee SS-J, Tsai H-C, Wann S-R, Chen J-K, Sy C-L et al (2011) Non-nosocomial healthcare-associated infective endocarditis in Taiwan: an underrecognized disease with poor outcome. BMC Infect Dis 11:221. doi:10.1186/1471-2334-11-221
106. Fedeli U, Schievano E, Buonfrate D, Pellizzer G, Spolaore P (2011) Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis 11:48
107. Math RS, Sharma G, Kothari SS, Kalaivani M, Saxena A, Kumar AS et al (2011) Prospective study of infective endocarditis from a developing country. Am Heart J 162:633–638. doi:10.1016/j.ahj. 2011.07.014
108. Sonneville R, Mirabel M, Hajage D, Tubach F, Vignon P, Perez P et al (2011) Neurologic complications and outcomes of infective endocarditis in critically ill patients: The ENDOcardite en REAnimation prospective multicenter study. Crit Care Med 39: 1474–1481
109. Rodriguez Y, Greenspon AJ, Sohail MR, Carrillo RG (2012) Cardiac device-related endocarditis complicated by spinal abscess: device-related endocarditis and spinal abscess. Pacing Clin Electrophysiol 35:269–274. doi:10.1111/j.1540-8159.2011. 03288.x
110. Montasser D, Bahadi A, Zajjari Y, Asserraji M, Alayoude A, Moujoud O et al (2011) Infective endocarditis in chronic hemodialysis patients: experience from Morocco. Saudi J Kidney Dis Transpl 22:160
111. Chen S-J, Chao T-F, Lin Y-J, Lo L-W, Hu Y-F, Tuan T-C et al (2012) Cool seasons are related to poor prognosis in patients with infective endocarditis. Int J Biometeorol 56:973–981. doi:10. 1007/s00484-011-0507-5
112. Olmos C, Vilacosta I, Fernandez C, Lopez J, Sarria C, Ferrera C et al (2013) Contemporary epidemiology and prognosis of septic shock in infective endocarditis. Eur Heart J 34:1999–2006. doi: 10.1093/eurheartj/ehs336
113. Fernández-Hidalgo N, Almirante B, Tornos P, González-Alujas MT, Planes AM, Galiñanes M et al (2012) Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 18:E522–E530. doi:10.1111/1469-0691.12033
114. Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG et al (2012) Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection 40:527–535. doi:10.1007/s15010-012-0285-y
115. Casalta J-P, Thuny F, Fournier P-E, Lepidi H, Habib G, Grisoli D et al (2012) DNA persistence and relapses questions on the treatment strategies of enterococcus infections of prosthetic valves. PLoS ONE 7:e53335. doi:10.1371/journal.pone.0053335
116. Dohmen PM, Guleri A, Capone A, Utili R, Seaton RA, Gonzalez-Ramallo VJ et al (2013) Daptomycin for the treatment of infective endocarditis: results from a European registry. J Antimicrob Chemother 68:936–942. doi:10.1093/jac/dks467
117. Deharo J-C, Quatre A, Mancini J, Khairy P, Le Dolley Y, Casalta J-P et al (2012) Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart 98:724–731. doi:10.1136/heartjnl-2012-301627
118. Ipek EG, Guray U, Demirkan B, Guray Y, Aksu T (2012) Infections of implantable cardiac rhythm devices: predisposing factors and outcome. Acta Cardiol 67:303–310
119. Whitaker J, Williams S, Arujuna A, Rinaldi CA, Chambers J, Klein JL (2012) Cardiac implantable electronic device-related endocarditis: a 12-year single-centre experience. Scand J Infect Dis 44:922–926. doi:10.3109/00365548.2012.701015
120. Roig IL, Darouiche RO, Musher DM, Trautner BW (2012) Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population. Scand J Infect Dis 44:753–760. doi:10.3109/00365548.2012.678882
121. Begezsán II, Bejan C, Ghibu L, Dorobăt CM, Roşu F (2012) Infective endocarditis in non-HIV immunosuppressed patients. Rev Medico-Chir Soc Medici Şi Nat Din Iaşi 116:687–691
122. Dzupova O, Machala L, Baloun R, Maly M, Benes J (2012) Incidence, predisposing factors, and aetiology of infective endocarditis in the Czech Republic. Scand J Infect Dis 44:250–255. doi:10.3109/00365548.2011.632643
123. Duval X, Delahaye F, Alla F, Tattevin P, Obadia J-F, Le Moing V et al (2012) Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications. J Am Coll Cardiol 59: 1968–1976. doi:10.1016/j.jacc.2012.02.029
124. Ashrafi R, McKay E, Ebden L, Jones J, Davis GK, Burgess MI (2012) Endocarditis in a large district general hospital: a study of the microbiological spectrum between 2000 and 2011. Exp Clin Cardiol 17:175
125. Fayad G, Vincentelli A, Leroy G, Devos P, Amr G, Prat A et al (2014) Impact of antimicrobial therapy on prognosis of patients requiring valve surgery during active infective endocarditis. J Thorac Cardiovasc Surg 147:254–258. doi:10.1016/j.jtcvs.2012. 10.019
126. Nakatani S, Mitsutake K, Ohara T, Kokubo Y, Yamamoto H, Hanai S et al (2013) Recent picture of infective endocarditis in Japan. Circ J 77:1558–1564. doi:10.1253/circj.CJ-12-1101